Upgrading a mass spectrometry facility for advanced proteomics research
Official title: A Bruker timsTOF HT mass spectrometer and nanoflow LC system to upgrade the proteomics facility at Rutgers-New Brunswick and Robert Wood Johnson Medical School
Funded at Rutgers Biomedical and Health Sciences · NIH-10851372 · Data updated 2026-11-12
This study is all about getting new, advanced equipment to help scientists at Rutgers and Robert Wood Johnson Medical School better understand proteins, which can help them learn more about diseases like cancer and metabolic disorders, ultimately leading to new treatments that could help patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project start | April 1, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $1,086,564 |
| NIH project number | 1S10OD036226-01 |
| Project ID | NIH-10851372 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals affected by conditions such as cancer, diabetes, and other diseases that involve protein abnormalities.
✕Less likely to help
Patients with conditions unrelated to protein analysis or those not participating in research studies at the facility may not receive direct benefits.
What this research studies
This research aims to enhance the capabilities of the proteomics facility at Rutgers-New Brunswick and Robert Wood Johnson Medical School by acquiring a state-of-the-art Bruker timsTOF HT mass spectrometer and NanoElute 2 liquid chromatography system. This new equipment will allow for more accurate and comprehensive analysis of proteins, which is crucial for understanding various diseases, including cancers and metabolic disorders. By integrating this advanced technology, researchers will be able to conduct more detailed studies on protein interactions and functions, ultimately leading to better insights into disease mechanisms. Patients may benefit indirectly through improved research outcomes that could lead to new treatments or diagnostic tools.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in the understanding and treatment of various diseases, including cancer and diabetes.
How similar studies have gone: Previous research has shown success with similar mass spectrometry approaches in enhancing proteomics capabilities, indicating a strong potential for impactful outcomes.
Where this research is happening
-
Rutgers Biomedical and Health Sciences
Newark, United States Active
Researchers
- Principal investigator: Zheng, Haiyan — Rutgers Biomedical and Health Sciences
- Study coordinator: Zheng, Haiyan
Related research
Other NIH-funded projects on the same topics.
-
Methylation and metabolism signals linked to lung function in kids with asthma
This grant looks at how genes, environment, and small chemical changes in the body together affect how lung function changes over time in children with asthma.
-
FEND-TB: Faster, better TB tests for all ages
A multi-institutional project aims to develop and validate faster TB diagnostic tools and drug-susceptibility tests so people of all ages, including children and those with extrapulmonary TB, can get quicker and more accurate results.
-
FEND-TB: Accelerating TB Diagnostics and Drug Susceptibility Testing
A multi‑institution collaboration will test new TB diagnostic tools and rapid drug-susceptibility tests to improve detection and treatment for people of all ages, including children and those with hard-to-diagnose TB.
-
Game-based mobile app to help pregnant women with overweight/obesity manage weight in Nepal
A new app designed for pregnant women in Nepal with overweight or obesity to help manage weight gain during pregnancy and reduce weight retention after birth.
-
Environmental factors and Lewy body dementia: linking claims data with lab work
Aims to find environmental factors that influence Lewy body dementia by combining big health data with lab studies, to understand what might worsen the condition and who is most at risk.
-
Identifying how ableism affects pregnancy and postpartum care for women with intellectual and developmental disabilities on Medicaid
This grant studies how bias and barriers in the healthcare system affect pregnancy and postpartum outcomes for women with intellectual and developmental disabilities who are on Medicaid and their babies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.